Recurrent retroperitoneal soft tissue sarcoma showing drastic reduction after pazopanib administration accompanied by severe liver dysfunction

Pazopanib is an orally bioavailable tyrosine kinase inhibitor anticancer drug approved worldwide for the treatment of metastatic renal cell carcinoma and advanced soft tissue sarcoma. Here we report the case of a patient whose recurrent retroperitoneal soft tissue sarcoma showed a drastic reduction...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Urol Case Rep
Autors principals: Okubo, Kazuki, Horiguchi, Akio, Ito, Keiichi, Asano, Tomohiko
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2018
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6041368/
https://ncbi.nlm.nih.gov/pubmed/30003043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2018.05.018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars